| Aug 8 |
CureVac N.V. (CVAC) Expected to Beat Earnings Estimates: Should You Buy?
|
| Aug 1 |
We Think CureVac (NASDAQ:CVAC) Can Afford To Drive Business Growth
|
| Jul 15 |
CureVac (CVAC) Upgraded to Buy: What Does It Mean for the Stock?
|
| Jul 13 |
Colorado reports three possible bird flu cases in humans
|
| Jul 11 |
CureVac Provides Trial Dates for Patent Litigation Against Pfizer, BioNTech
|
| Jul 11 |
CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech
|
| Jul 5 |
An Intrinsic Calculation For CureVac N.V. (NASDAQ:CVAC) Suggests It's 47% Undervalued
|
| Jul 4 |
CureVac: GSK's Deal For Infectious Disease Assets Is A Long-Shot For Both Pharmas
|
| Jul 4 |
GSK Buys Flu, COVID mRNA Jab Rights From Partner CureVac
|
| Jul 4 |
Biotech Stock Roundup: GSK, CVAC Revise Agreement, Updates From MRNA, RNAC & More
|
